Doximity Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Doximity Stock Forecast and Price Target
The average price target for Doximity's stock set by seven recognized analysts recently is $29.00, which would result in a potential upside of approximately 19.24% if it reached this mark. The estimation is based on a high estimate of $35.00 and a low estimate of $25.00. If you are interested in DOCS stock, it is important to also consider its competitors.
19.24% Upside
Doximity Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Doximity's Price has decreased from $12.30 to $0.00 – a 100.00% drop. Next year, analysts are expecting Fair Value to reach $0.00 – an increase of 100.00%. Over the next five years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MSFT Stock Forecast | Microsoft Corp | Buy |
18
|
$397.84 | Buy/Sell | $465.63 | 19.39% |
| META Stock Forecast | Meta Platforms | Buy |
13
|
$441.68 | Buy/Sell | $513.85 | 18.30% |
| ZM Stock Forecast | Zoom Video Communications | Hold |
16
|
$62.83 | Buy/Sell | $79.36 | 22.55% |
| CARG Stock Forecast | CarGurus | Outperform |
14
|
$22.91 | Buy/Sell | $24.08 | 13.49% |
| TDOC Stock Forecast | Teladoc Health | Hold |
7
|
$12.99 | Buy/Sell | $23.31 | 23.17% |
Doximity Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Doximity's Revenue has grown from $206.90M to $419.05M – a 102.54% increase. For the following year, the 0 analysts predict that Doximity's Revenue will drop by 25.27%, reaching $313.14M. In 2030, the professionals' prediction is that DOCS's Revenue will decrease by 24.03%, reaching $318.35M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDRX Stock Forecast | Veradigm | Outperform |
13
|
$7.80 | Buy/Sell | $16.33 | 53.85% |
| TTGT Stock Forecast | TechTarget | Outperform |
16
|
$28.77 | Buy/Sell | $31.60 | 40.77% |
| AMWL Stock Forecast | American Well | Outperform |
9
|
$0.52 | Buy/Sell | $2.16 | 284.62% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VERI Stock Forecast | Veritone | Hold |
8
|
$3.28 | Buy/Sell | $2.38 | 21.95% |
| DHX Stock Forecast | DHI Group | Buy |
14
|
$2.61 | Buy/Sell | $5.50 | 110.73% |
| HLYK Stock Forecast | HealthLynked | - |
0
|
$0.06 | Buy/Sell | $0.00 | -100.00% |
Doximity EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Doximity's EBITDA has grown, rising from $54.81M to $131.35M – a growth of 139.65%. According to the 0 analysts polled, in the next year, Doximity's EBITDA will fall by 25.63%, reaching $97.69M. By 2030, professionals believe that Doximity's EBITDA will have decreased by 24.43%, falling to $99.26M.
Doximity EBIT Forecast for 2023 - 2025 - 2030
Doximity's EBIT has grown In the last two years, rising from $53.30M to $125.87M – a growth of 136.15%. For the next year, 0 analysts project Doximity's EBIT to drop by 24.12%, reaching $95.51M. By 2030, professionals believe that Doximity's EBIT will decrease by 23.24%, reaching $96.62M – a concerning trend for the company.
Doximity EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Doximity's EPS has decreased from $0.82 to $0.00 – a 100.00% drop. Next year, analysts are expecting EPS to reach $0.00 – an increase of 100.00%. Over the next five years, the forecast is for EPS to grow by 100.00%.
.jpg)